Kolkata, 700160,
India
Tata Translational Cancer Research Centre Technographics
Discover the latest software purchases and digital transformation initiatives being undertaken by Tata Translational Cancer Research Centre and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 800 Tata Translational Cancer Research Centre employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Tata Translational Cancer Research Centre has purchased the following applications: TCS ADD for Clinical Trial Management in 2016 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Tata Translational Cancer Research Centre is running and its propensity to invest more and deepen its relationship with Tata Consultancy Services or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Tata Translational Cancer Research Centre revenues, which have grown to $200.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Tata Translational Cancer Research Centre intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
ERP Services and Operations
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Tata Consultancy Services | Legacy | TCS ADD | Clinical Trial Management | ERP Services and Operations | n/a | 2016 | 2017 |
In 2016 Tata Translational Cancer Research Centre implemented TCS ADD Integrated Data Management IDM as its Clinical Trial Management platform. The deployment uses TCS ADD as the electronic data capture platform to run the Icicle multicentre therapeutic trial and to support clinical database development in India.
Configuration focused on explicit module adoption listed on TTCRC materials, including EDC, terminology management, medical coding, and non-CRF data handling. The implementation encompassed clinical database build and form-level data capture workflows, with data validation and standard coding processes configured through the TCS ADD Integrated Data Management application.
Tata Consultancy Services provides associated clinical data management and analytics services for the study, embedding TCS ADD into operational workflows for clinical data management and analytics teams across the trial sites in India. Operational coverage centers on multicentre trial data capture and regulatory reporting pipelines, aligning the Clinical Trial Management system with study reporting and submission needs.
Governance included centralized module usage and operational handoffs between TTCRC investigational teams and TCS data services, with terminology management and medical coding established to support regulatory reporting. Reported outcomes for the installation include improved data capture and regulatory reporting efficiency as part of the TCS ADD deployment.
|
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||